Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin Treatment for Multi-Drug Resistant Extrapulmonary Tuberculosis in Canada: A Report.

Saved in:
Bibliographic Details
Title: Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin Treatment for Multi-Drug Resistant Extrapulmonary Tuberculosis in Canada: A Report.
Authors: Fung JS; Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada., Cook VJ; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Provincial Tuberculosis Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Johnston J; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Provincial Tuberculosis Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada., Connors WJ; Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Provincial Tuberculosis Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
Source: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada [J Assoc Med Microbiol Infect Dis Can] 2025 Feb 26; Vol. 10 (2), pp. 203-208. Date of Electronic Publication: 2025 Feb 26 (Print Publication: 2025).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: University of Toronto Press Country of Publication: Canada NLM ID: 101763536 Publication Model: eCollection Cited Medium: Internet ISSN: 2371-0888 (Electronic) Linking ISSN: 23710888 NLM ISO Abbreviation: J Assoc Med Microbiol Infect Dis Can Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2371-0888
DOI:10.3138/jammi-2024-0025